<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">

  <!-- PACE Progress Bar START -->
  
    
<script src="https://raw.githubusercontent.com/HubSpot/pace/v1.0.2/pace.min.js"></script>

    
<link rel="stylesheet" href="https://github.com/HubSpot/pace/raw/master/themes/orange/pace-theme-flash.css">

  
  

  <!-- PACE Progress Bar START -->

  
  <title>Yujie&#39;s Blog</title>
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  
  
  
  
  <meta name="description" content="文章来源：《经济学人》Dec 18th 2021 期 Britain 栏目 The triumph of the Oxford-AstraZeneca vaccine牛津-阿斯利康疫苗的成功 A dose for the world Despite setbacks, the jab has probably saved more lives than any other尽管遇到了挫折，但注射该疫">
<meta property="og:type" content="article">
<meta property="og:title" content="Yujie&#39;s Blog">
<meta property="og:url" content="http://example.com/2021/12/17/Day611-The%20Economist/index.html">
<meta property="og:site_name" content="Yujie&#39;s Blog">
<meta property="og:description" content="文章来源：《经济学人》Dec 18th 2021 期 Britain 栏目 The triumph of the Oxford-AstraZeneca vaccine牛津-阿斯利康疫苗的成功 A dose for the world Despite setbacks, the jab has probably saved more lives than any other尽管遇到了挫折，但注射该疫">
<meta property="og:locale">
<meta property="og:image" content="https://www.economist.com/img/b/1280/720/90/sites/default/files/images/2021/12/articles/main/20211218_brp002.jpg">
<meta property="og:image" content="https://www.economist.com/img/b/608/662/90/sites/default/files/images/2021/12/articles/body/20211218_brc248.png">
<meta property="og:image" content="https://www.economist.com/img/b/608/1498/90/sites/default/files/images/2021/12/articles/body/20211218_brc246.png">
<meta property="article:published_time" content="2021-12-17T05:46:32.445Z">
<meta property="article:modified_time" content="2021-12-23T04:03:14.743Z">
<meta property="article:author" content="Chen Yujie">
<meta name="twitter:card" content="summary">
<meta name="twitter:image" content="https://www.economist.com/img/b/1280/720/90/sites/default/files/images/2021/12/articles/main/20211218_brp002.jpg">
  
    <link rel="alternate" href="/atom.xml" title="Yujie&#39;s Blog" type="application/atom+xml">
  
  <link rel="icon" href="/css/images/favicon.ico">
  
    <link href="//fonts.googleapis.com/css?family=Source+Code+Pro" rel="stylesheet" type="text/css">
  
  <link href="https://fonts.googleapis.com/css?family=Open+Sans|Montserrat:700" rel="stylesheet" type="text/css">
  <link href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic" rel="stylesheet" type="text/css">
  <link href="https://cdn.bootcss.com/font-awesome/4.6.3/css/font-awesome.min.css" rel="stylesheet">
  <style type="text/css">
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/9749f0/00000000000000000001008f/27/l?subset_id=2&fvd=n5) format("woff2");font-weight:500;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/90cf9f/000000000000000000010091/27/l?subset_id=2&fvd=n7) format("woff2");font-weight:500;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/8a5494/000000000000000000013365/27/l?subset_id=2&fvd=n4) format("woff2");font-weight:lighter;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/d337d8/000000000000000000010095/27/l?subset_id=2&fvd=i4) format("woff2");font-weight:400;font-style:italic;}</style>
    
  <link rel="stylesheet" id="athemes-headings-fonts-css" href="//fonts.googleapis.com/css?family=Yanone+Kaffeesatz%3A200%2C300%2C400%2C700&amp;ver=4.6.1" type="text/css" media="all">
  
<link rel="stylesheet" href="/css/style.css">


  
<script src="https://code.jquery.com/jquery-3.1.1.min.js"></script>


  <!-- Bootstrap core CSS -->
  <link rel="stylesheet" href="https://netdna.bootstrapcdn.com/bootstrap/3.0.2/css/bootstrap.min.css" >
  <link rel="stylesheet" href="/css/hiero.css" >
  <link rel="stylesheet" href="/css/glyphs.css" >
  
    <link rel="stylesheet" href="/css/vdonate.css" >
  

  <!-- Custom CSS -->
  
<link rel="stylesheet" href="/css/my.css">

  <!-- Google Adsense -->
  
  <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
  <script>
      (adsbygoogle = window.adsbygoogle || []).push({
          google_ad_client: "ca-pub-0123456789ABCDEF",
          enable_page_level_ads: true
      });
  </script>
  
<meta name="generator" content="Hexo 6.3.0"></head>

<script>
var themeMenus = {};

  themeMenus["/"] = "Home"; 

  themeMenus["/archives"] = "Archives"; 

  themeMenus["/categories"] = "Categories"; 

  themeMenus["/tags"] = "Tags"; 

  themeMenus["/about"] = "About"; 

</script>


  <body data-spy="scroll" data-target="#toc" data-offset="50">


  <header id="allheader" class="site-header" role="banner">
  <div class="clearfix container">
      <div class="site-branding">

          <h1 class="site-title">
            
              <a href="/" title="Yujie&#39;s Blog" rel="home"> Yujie&#39;s Blog </a>
            
          </h1>

          
            <div class="site-description">Welcome to my channel</div>
          
            
          <nav id="main-navigation" class="main-navigation" role="navigation">
            <a class="nav-open">Menu</a>
            <a class="nav-close">Close</a>
            <div class="clearfix sf-menu">

              <ul id="main-nav" class="nmenu sf-js-enabled">
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/">Home</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/archives">Archives</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/categories">Categories</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/tags">Tags</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/about">About</a> </li>
                    
              </ul>
            </div>
          </nav>


      </div>
  </div>
</header>


  <div id="originBgDiv" style="background: #fff; width: 100%;">

      <div style="max-height:600px; overflow: hidden;  display: flex; display: -webkit-flex; align-items: center;">
        <img id="originBg" width="100%" alt="" src="">
      </div>

  </div>

  <script>
  function setAboutIMG(){
      var imgUrls = "css/images/pose.jpg,https://source.unsplash.com/collection/954550/1920x1080".split(",");
      var random = Math.floor((Math.random() * imgUrls.length ));
      if (imgUrls[random].startsWith('http') || imgUrls[random].indexOf('://') >= 0) {
        document.getElementById("originBg").src=imgUrls[random];
      } else {
        document.getElementById("originBg").src='/' + imgUrls[random];
      }
  }
  bgDiv=document.getElementById("originBgDiv");
  if(location.pathname.match('about')){
    setAboutIMG();
    bgDiv.style.display='block';
  }else{
    bgDiv.style.display='none';
  }
  </script>



  <div id="container">
    <div id="wrap">
            
      <div id="content" class="outer">
        
          <section id="main" style="float:none;"><article id="post-Day611-The Economist" style="width: 66%; float:left;" class="article article-type-post" itemscope itemprop="blogPost" >
  <div id="articleInner" class="clearfix post-1016 post type-post status-publish format-standard has-post-thumbnail hentry category-template-2 category-uncategorized tag-codex tag-edge-case tag-featured-image tag-image tag-template">
    
    
    <div class="article-meta">
      
	Posted on <a href="/2021/12/17/Day611-The%20Economist/" class="article-date">
	  <time datetime="2021-12-17T05:46:32.445Z" itemprop="datePublished">December 17, 2021</time>
	</a>

      
	<span id="busuanzi_container_page_pv">
	  本文总阅读量<span id="busuanzi_value_page_pv"></span>次
	</span>

    </div>
    <div class="article-entry" itemprop="articleBody">
      
        <p>文章来源：《经济学人》Dec 18th 2021 期 Britain 栏目</p>
<h1 id="The-triumph-of-the-Oxford-AstraZeneca-vaccine"><a href="#The-triumph-of-the-Oxford-AstraZeneca-vaccine" class="headerlink" title="The triumph of the Oxford-AstraZeneca vaccine"></a>The triumph of the Oxford-AstraZeneca vaccine</h1><p>牛津-阿斯利康疫苗的成功</p>
<h6 id="A-dose-for-the-world"><a href="#A-dose-for-the-world" class="headerlink" title="A dose for the world"></a>A dose for the world</h6><p><img src="https://www.economist.com/img/b/1280/720/90/sites/default/files/images/2021/12/articles/main/20211218_brp002.jpg"></p>
<h5 id="Despite-setbacks-the-jab-has-probably-saved-more-lives-than-any-other"><a href="#Despite-setbacks-the-jab-has-probably-saved-more-lives-than-any-other" class="headerlink" title="Despite setbacks, the jab has probably saved more lives than any other"></a>Despite setbacks, the jab has probably saved more lives than any other</h5><p>尽管遇到了挫折，但注射该疫苗拯救的生命可能比其他任何方法都要多</p>
<p>Dec 16th 2021</p>
<p>[文章音频](<a target="_blank" rel="noopener" href="https://www.economist.com/media-assets/audio/034%20Britain%20-%20Covid-19-5b81c8107477b30b052b5a9debb3e753.mp3">https://www.economist.com/media-assets/audio/034%20Britain%20-%20Covid-19-5b81c8107477b30b052b5a9debb3e753.mp3</a>“ title&#x3D;”The triumph of the Oxford-AstraZeneca vaccine)</p>
<p>IN A SOLEMN pre-recorded address, Boris Johnson <strong>warned Britons that</strong> a “tidal wave” of Omicron was on its way, <strong>and that</strong> the best chance of escape lay in booster vaccines. All adults, the prime minister announced on December 12th, would be offered one by the end of 2021. Yet their choice is to be more limited than in the last vaccination push, with Moderna and Pfizer leading the way. Nearly a year after it was first approved, Britain’s flagship Oxford-AstraZeneca jab will be rarely used.</p>
<p>在一个严肃的预先录制的演讲中，鲍里斯·约翰逊警告英国人，奥密克戎“浪潮”即将到来，而避开(奥密克戎)最好的“机会”在于加强针。英国首相在12月12日宣布，到2021年底，所有成年人都将有机会接种一剂加强针。然而，他们的选择比上次的疫苗接种运动更加有限，由Moderna和Pfizer牵头。英国的“旗舰产品”牛津-阿斯利康疫苗在首次获批近一年后，仍然很少被使用。</p>
<p><img src="https://www.economist.com/img/b/608/662/90/sites/default/files/images/2021/12/articles/body/20211218_brc248.png" alt="img"></p>
<p>It is the latest indignity for a vaccine that is both a national symbol—praised by royalty, hawked around the world by the prime minister, made by the country’s most famous university and biggest listed company—and a source of angst. Astra Zeneca has <strong>taken flak for</strong> data-presentation issues, delayed deliveries and rare adverse events. The share prices of Moderna and Pfizer have soared since covid-19 struck; AstraZeneca’s is pretty much back where it started (see chart 1).</p>
<figure class="highlight plaintext"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><span class="line">【1】hawk 推销；叫卖</span><br><span class="line">【2】angst 尤指对私人问题的）焦虑，烦忧</span><br><span class="line">【3】take the flak for sth 因某事遭到抨击</span><br></pre></td></tr></table></figure>

<p>疫苗既是国家的象征(受到皇室的赞扬，由英国首相在世界各地兜售，由该国最著名的大学和最大的上市公司生产)，也成为了焦虑的来源，这是对疫苗的最新侮辱。阿斯利康因数据显示问题、交货延迟和罕见的不良事件而备受指责。自新冠爆发以来，Moderna和Pfizer的股价大幅上涨; 阿斯利康的股价则已经基本回到了起点(见表1)。</p>
<p>Nor, <strong>to the bemusement of many involved</strong>, has the company won a great public-relations victory. On some measures, it manufactures the most successful covid vaccine there is. According to Airfinity, a data firm, 2.2bn doses have been delivered, compared with 2bn by Pfizer and 0.5bn by Moderna (see chart 2). Because rich countries increasingly use other jabs, and poor countries mostly use their supply for initial doses rather than for boosters, Astra Zeneca’s vaccine is almost certain to have saved more lives than any other.</p>
<figure class="highlight plaintext"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><span class="line">【1】bemusement 困惑</span><br></pre></td></tr></table></figure>

<p>令许多相关人士感到困惑的是，该公司也没有赢得重大的公关胜利。在某些方面，它生产的是目前最成功的covid疫苗。根据数据公司Airfinity的数据，其已经“兑现”了22亿剂疫苗，相比之下，Pfizer公司只有了20亿剂，Moderna只有5亿剂(见图2)。由于发达国家越来越多地使用其他疫苗，而贫穷国家大多将这些疫苗用于初始疫苗接种，而非作为加强针接种，几乎可以肯定，阿斯利康公司的疫苗比其他公司的疫苗可以挽救更多的生命。</p>
<p><img src="https://www.economist.com/img/b/608/1498/90/sites/default/files/images/2021/12/articles/body/20211218_brc246.png" alt="img"></p>
<p>Yet it was always unlikely to be a big money-spinner. Ministers were happy for it to be sold at a small profit; the University of Oxford, which came up with the vaccine, was not, both for humanitarian reasons and to avoid being “seen to be cashing in on what was inevitably going to be an enormous amount of human suffering”, says Sir John Bell, Regius professor of medicine at the university. A dose sells at less than $4, compared with more than $20 for Pfizer. “Do [AstraZeneca bosses] look at Pfizer’s [profit and loss] and say, ‘Oh, shit, how did that happen?’ You know, they might,” says Sir John. <strong>But it was agreed to be the right thing to do</strong>, he adds.</p>
<figure class="highlight plaintext"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><span class="line">【1】money-spinner 摇钱树；赚大钱的企业</span><br><span class="line">【2】cash in on 从..中获利</span><br></pre></td></tr></table></figure>

<p>然而，它一直不太可能成为一个赚大钱的企业。部长们很高兴它能以微薄的利润出售; 研制出疫苗的牛津大学则非出于此原因，而是因为这既是出于人道主义原因，也是为了避免“被视为在利用‘不可避免的人类巨大的痛苦’赚钱”，牛津大学Regius医学教授John Bell爵士表示。一剂疫苗的售价不到4美元，而Pfizer的售价超过20美元。John 爵士说：“(阿斯利康的老板)会不会看着Pfizer的(盈利和亏损)说，‘哦，该死，怎么会这样?’ 你知道，他们可能会的”。但他补充说，大家一致认为这是正确的做法。</p>
<p>AstraZeneca’s vaccine has <strong>struggled for market share</strong> in the rich world. Relations with America’s Food and Drug Administration (FDA) soured after the firm failed to notify the regulator about a possible adverse event in a trial elsewhere; the FDA has still not approved the vaccine. After AstraZeneca failed to meet the European Union’s delivery targets, national leaders criticised it and the commission placed an enormous order with Pfizer. “The truth is AstraZeneca had signed an exclusivity deal with us and a best-efforts deal with the European Union,” says Matt Hancock, Britain’s health secretary at the time.</p>
<p>阿斯利康的疫苗在发达国家一直在努力争取市场份额。由于该公司未能向FDA通报在其他地方的一项试验中可能出现的不良事件，与FDA的关系恶化; FDA还没有批准这种疫苗。在阿斯利康未能达到欧盟的兑现目标后，各国领导人批评了阿斯利康，欧盟委员会则和Pfizer达成了一笔巨额订单。时任英国卫生大臣的Matt Hancock表示:“ 事实是，阿斯利康与我们签署了一项排他协议，并与欧盟签署了一项尽最大努力的协议。”</p>
<p>The vaccine, which uses an adenoviral vector, has proved less effective than its mRNA rivals at stopping infection, further reducing demand in the rich world, and is perhaps marginally less effective at preventing death. Soon after it became available, evidence emerged that in rare cases it caused blood clots (as does Johnson &amp; Johnson’s vaccine, another adenoviral-vector jab). This helped persuade the JCVI, an expert body, to recommend using other vaccines in Britain’s booster round. Sir Menelas Pangalos, AstraZeneca’s head of research, says the firm hopes to tweak the recipe to avoid the issue.</p>
<p>这种使用腺病毒载体的疫苗被证明在阻止感染方面不如其mRNA疫苗对手有效，这进一步减少了发达国家的需求，而且在预防死亡方面可能稍微没那么有效。这种疫苗问世后不久，就有证据表明，在极少数情况下，它会导致血栓 (就像强生公司的疫苗一样，强生公司的疫苗是另一种腺病毒载体疫苗)。这帮助说服了专家机构JCVI，建议在英国加强针接种中使用其他疫苗。阿斯利康公司研究主管Menelas Pangalos爵士表示，公司希望通过调整‘配方’来避免这一问题。</p>
<p>But, he adds, there is “little to no” evidence of such adverse events outside the West: “It may be driven by genetics, it may be driven by overreporting, who knows?” Indeed, AstraZeneca’s vaccine is increasingly used elsewhere. Since production surged in September, the countries with the most doses are India (which banned the export of vaccines made there), Brazil and Mexico. Covax, which distributes jabs to poor countries, is another beneficiary. The vaccine is “starting to hit places like Malaysia, Nepal, Vietnam and Thailand, and there’s a ton of people in these countries”, notes Sir John.</p>
<p>但是，他补充道，在西方以外，“几乎没有”这样的不良事件的证据:“ 这可能是由基因造成的，也可能是由过度报道造成的，谁知道呢?” 事实上，阿斯利康的疫苗在其他地方越来越多地使用。自9月疫苗产量激增以来，疫苗数量最多的国家是印度(该国禁止出口本国生产的疫苗)、巴西和墨西哥。向贫穷国家分发疫苗的Covax是另一个受益者。John爵士指出，这种疫苗“开始在马来西亚、尼泊尔、越南和泰国等地流行，这些国家有大量人口”。</p>
<p>The surge of deliveries in the second half of 2021 is the flipside of AstraZeneca’s struggles in the first. The firm worked with partners to establish 25 manufacturing facilities in 15 countries. Its vaccines are made to a formula detailing just about everything that can be controlled in a production facility. At first the firm’s scientists were too optimistic about how quickly output yields would rise, but reality has since caught up. India’s Serum Institute illustrates the scale of the growth. In January it made fewer than 60m doses; by November it had hit 250m.</p>
<p>2021年下半年的“交付激增”的情况与阿斯利康在第一季度的困境局面正好相反。该公司与其合作伙伴在15个国家建立了25个生产中心。该公司的疫苗配方详细描述了生产中心可控的所有东西。起初，公司的科学家们对产量增长的速度过于乐观，但现实给他们“迎头一棒”。印度血清研究所说明了这种增长的规模。一月份，它的产量不到6000万剂疫苗; 到11月，它的产量已经达到了2.5亿。</p>
<p><strong>One question is</strong> whether there will be another inversion in 2022, with demand failing to meet potential output. In November AstraZeneca said it would start to make a profit on doses, and had signed deals on that basis for 2022, with prices on a sliding scale depending on the wealth of the purchaser (the vaccine will remain available to poor countries at cost, and even in richer ones the firm will still charge less than its rivals). <strong>Its two main selling points are cheapness and the logistical advantage that doses do not need to be kept very cold.</strong> AstraZeneca has established a new internal unit for its vaccines, as well as its promising antibody therapy, which was approved by America’s FDA on December 8th. This can prevent covid in people who do not respond to vaccines, including the immune-suppressed.</p>
<p>一个问题是，2022年是否还会出现另一次反转，届时需求将无法满足潜在产出。阿斯利康11月表示, 将从疫苗上开始获利,并且在此基础上签署了2022年的协议, 价格按买方的财富高低而浮动(疫苗仍将以成本价提供给贫穷国家,甚至在发达国家，阿斯利康公司收取的费用仍低于其竞争对手)。它的两个主要卖点是价格低廉和不需要储存在非常冷的条件下的物流优势。阿斯利康已经为其疫苗以及其看好前景的抗体疗法建立了一个新的内部部门，该疗法于12月8日获得了FDA的批准。这可以在对疫苗没有反应的人群中预防covid，包括免疫抑制患者。</p>
<p>Forecasting demand has been made difficult by Omicron, against which two doses of AstraZeneca appear to offer scant protection from infection and reduced protection from hospitalisation. If vaccines need to be retooled, the process will take a bit longer than for mRNA jabs. Even if demand outside the rich world remains high, analysts do not expect the vaccine to contribute much to AstraZeneca’s bottom line, especially when compared with the firm’s strengths in oncology and cardiovascular disease. “When I think about the stock, I don’t even think about the vaccine as a driver,” says Gareth Powell of Polar Capital, an investor in the firm.</p>
<p>由于应对奥密克戎，两剂阿斯利康疫苗对感染的保护作用不足，而且对住院治疗的保护作用也较弱，需求预测变得困难。如果疫苗需要重组，这个过程将比mRNA疫苗的要长一些。即使发达国家以外的需求仍然很高，分析师们也不期望该疫苗对阿斯利康的利润有多大贡献，尤其是与该公司在肿瘤和心血管疾病方面相比。该公司的投资者、Polar Capital的Gareth Powell 说：“当我想到股票的时候，我甚至都不会去想疫苗是一个驱动因素”。</p>
<p>Pascal Soriot, AstraZeneca’s boss, has always insisted the decision to make the vaccine was fundamentally altruistic rather than commercial, saying that his children would have killed him if he did not take the chance. Given the number of storms his firm has had to weather, and the attention the vaccine has absorbed, shareholders may not be entirely grateful for the gamble. Everyone else should be. ■</p>
<p>阿斯利康的老板Pascal Soriot一直坚称，生产疫苗的决定从根本上说是利他主义的，而非要在商业上获利，他说，如果他不抓住机会，他的孩子们就会杀了他。考虑到他的公司经受的风风雨雨，以及疫苗所吸引的关注，股东们可能不会完全感激这场“冒险”。但其他所有人应该对此表示感激。■</p>

      
    </div>
    <footer class="entry-meta entry-footer">
      
      
      
        <div id="donation_div"></div>


<script src="/js/vdonate.js"></script>

<script>
var a = new Donate({
  title: '如果觉得我的文章对您有用，请随意打赏。您的支持将鼓励我继续创作!', // 可选参数，打赏标题
  btnText: 'Donate', // 可选参数，打赏按钮文字
  el: document.getElementById('donation_div'),
  wechatImage: 'https://raw.githubusercontent.com/iTimeTraveler/iTimeTraveler.github.io/site/source/about/donate/images/WeChanQR.png',
  alipayImage: 'https://raw.githubusercontent.com/iTimeTraveler/iTimeTraveler.github.io/site/source/about/donate/images/AliPayQR.jpg'
});
</script>
      
            
      
        
	<div id="comment">
		<!-- 来必力City版安装代码 -->
		<div id="lv-container" data-id="city" data-uid="MTAyMC8yOTQ4MS82MDQ5">
		<script type="text/javascript">
		   (function(d, s) {
		       var j, e = d.getElementsByTagName(s)[0];

		       if (typeof LivereTower === 'function') { return; }

		       j = d.createElement(s);
		       j.src = 'https://cdn-city.livere.com/js/embed.dist.js';
		       j.async = true;

		       e.parentNode.insertBefore(j, e);
		   })(document, 'script');
		</script>
		<noscript>为正常使用来必力评论功能请激活JavaScript</noscript>
		</div>
		<!-- City版安装代码已完成 -->
	</div>


      
    </footer>
  </div>
  
    
<nav id="article-nav">
  
    <a href="/2021/12/17/Day612-The%20Economist/" id="article-nav-newer" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Newer</strong>
      <div class="article-nav-title">
        
          (no title)
        
      </div>
    </a>
  
  
    <a href="/2021/12/17/Day610-The%20Economist/" id="article-nav-older" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Older</strong>
      <div class="article-nav-title"></div>
    </a>
  
</nav>

  
</article>

<!-- Table of Contents -->

  <aside id="sidebar">
    <div id="toc" class="toc-article" style="overflow-y: scroll; max-width: 28%;">
    <strong class="toc-title">Contents</strong>
    
      <ol class="nav"><li class="nav-item nav-level-1"><a class="nav-link" href="#The-triumph-of-the-Oxford-AstraZeneca-vaccine"><span class="nav-number">1.</span> <span class="nav-text">The triumph of the Oxford-AstraZeneca vaccine</span></a><ol class="nav-child"><li class="nav-item nav-level-6"><a class="nav-link" href="#A-dose-for-the-world"><span class="nav-number">1.0.0.0.0.1.</span> <span class="nav-text">A dose for the world</span></a></li></ol></li><li class="nav-item nav-level-5"><a class="nav-link" href="#Despite-setbacks-the-jab-has-probably-saved-more-lives-than-any-other"><span class="nav-number">1.0.0.0.1.</span> <span class="nav-text">Despite setbacks, the jab has probably saved more lives than any other</span></a></li></ol></li></ol></li></ol></li></ol></li></ol>
    
    </div>
  </aside>
</section>
        
      </div>
      <footer id="footer" class="site-footer">
  

  <div class="clearfix container">
      <div class="site-info">
	      &copy; 2023 Yujie&#39;s Blog All Rights Reserved.
          
            <span id="busuanzi_container_site_uv">
              本站访客数<span id="busuanzi_value_site_uv"></span>人次  
              本站总访问量<span id="busuanzi_value_site_pv"></span>次
            </span>
          
      </div>
      <div class="site-credit">
        Theme by <a href="https://github.com/iTimeTraveler/hexo-theme-hiero" target="_blank">hiero</a>
      </div>
  </div>
</footer>


<!-- min height -->

<script>
    var contentdiv = document.getElementById("content");

    contentdiv.style.minHeight = document.body.offsetHeight - document.getElementById("allheader").offsetHeight - document.getElementById("footer").offsetHeight + "px";
</script>

<!-- Custome JS -->

<script src="/js/my.js"></script>

    </div>
    <!-- <nav id="mobile-nav">
  
    <a href="/" class="mobile-nav-link">Home</a>
  
    <a href="/archives" class="mobile-nav-link">Archives</a>
  
    <a href="/categories" class="mobile-nav-link">Categories</a>
  
    <a href="/tags" class="mobile-nav-link">Tags</a>
  
    <a href="/about" class="mobile-nav-link">About</a>
  
</nav> -->
    

<!-- mathjax config similar to math.stackexchange -->

<script type="text/x-mathjax-config">
  MathJax.Hub.Config({
    tex2jax: {
      inlineMath: [ ['$','$'], ["\\(","\\)"] ],
      processEscapes: true
    }
  });
</script>

<script type="text/x-mathjax-config">
    MathJax.Hub.Config({
      tex2jax: {
        skipTags: ['script', 'noscript', 'style', 'textarea', 'pre', 'code']
      }
    });
</script>

<script type="text/x-mathjax-config">
    MathJax.Hub.Queue(function() {
        var all = MathJax.Hub.getAllJax(), i;
        for(i=0; i < all.length; i += 1) {
            all[i].SourceElement().parentNode.className += ' has-jax';
        }
    });
</script>

<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.4/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
</script>



  
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/2.1.5/jquery.fancybox.min.css">

  
<script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/2.1.5/jquery.fancybox.min.js"></script>




<script src="/js/scripts.js"></script>


<script src="https://stackpath.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js"></script>


<script src="/js/main.js"></script>








  <div style="display: none;">
    <script src="https://s95.cnzz.com/z_stat.php?id=1260716016&web_id=1260716016" language="JavaScript"></script>
  </div>



	<script async src="https://dnqof95d40fo6.cloudfront.net/atw7f8.js">
	</script>






  </div>

  <a id="rocket" href="#top" class=""></a>
  <script type="text/javascript" src="/js/totop.js" async=""></script>
</body>
</html>
